Publications

1. Wiedmeier-Nutor JE, Fonseca R. Hyperdiploid myeloma: The silent majority. Br J Haematol. 2025 Aug; 207 (2):365-368 Epub 2025 June 09
   View PubMed
2. Wiedmeier-Nutor JE, Fonseca R. Hyperdiploid myeloma: The silent majority. Br J Haematol. 2025 Aug; 207 (2):365-368 Epub 2025 June 09
   View PubMed
3. Diamond BT, Baughn LB, Poorebrahim M, Poos AM, Lee H, Kaddoura M, Wiedmeier-Nutor JE, Durante MA, Otteson GE, Jevremovic D, Tang H, Frohling S, Baertsch MA, Papadimitriou M, Ziccheddu B, Jelinek T, Lemoine C, Rak A, Green DJ, Landgren CO, Neri P, Bergsagel PL, Braggio E, Kumar SK, Raab MS, Fonseca R, Bahlis N, Weinhold N, Maura F. Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma. Blood. 2025 Jun 10 Epub 2025 June 10
   View PubMed
4. Diamond BT, Baughn LB, Poorebrahim M, Poos AM, Lee H, Kaddoura M, Wiedmeier-Nutor JE, Durante MA, Otteson GE, Jevremovic D, Tang H, Frohling S, Baertsch MA, Papadimitriou M, Ziccheddu B, Jelinek T, Lemoine C, Rak A, Green DJ, Landgren CO, Neri P, Bergsagel PL, Braggio E, Kumar SK, Raab MS, Fonseca R, Bahlis N, Weinhold N, Maura F. Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma. Blood. 2025 Jun 10 Epub 2025 June 10
   View PubMed
5. Bolarinwa A, Nagaraj M, Zanwar S, Abdallah N, Bergsagel PL, Binder M, Buadi F, Chhabra S, Cook J, Dingli D, Dispenzieri A, Gertz MA, Gonsalves W, Hayman S, Kapoor P, Kourelis T, Leung N, Lin Y, Muchtar E, Parrondo R, Roy V, Sher T, Siddiqui M, Warsame R, Fonder A, Hobbs M, Hwa YL, Rogers M, Yadav U, Wiedmeier-Nutor JE, Baughn LB, Vincent Rajkumar S, Fonseca R, Ailawadhi S, Kumar S. Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes. Blood Cancer J. 2025 Apr 4; 15 (1):57 Epub 2025 Apr 04
   View PubMed
6. Bolarinwa A, Nagaraj M, Zanwar S, Abdallah N, Bergsagel PL, Binder M, Buadi F, Chhabra S, Cook J, Dingli D, Dispenzieri A, Gertz MA, Gonsalves W, Hayman S, Kapoor P, Kourelis T, Leung N, Lin Y, Muchtar E, Parrondo R, Roy V, Sher T, Siddiqui M, Warsame R, Fonder A, Hobbs M, Hwa YL, Rogers M, Yadav U, Wiedmeier-Nutor JE, Baughn LB, Vincent Rajkumar S, Fonseca R, Ailawadhi S, Kumar S. Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes. Blood Cancer J. 2025 Apr 4; 15 (1):57 Epub 2025 Apr 04
   View PubMed
7. Fonseca R, Zhu YX, Bruins LA, Ahmann J, de Bonolo Campos C, Braggio E, Chen X, Arribas M, Darvish S, Welsh S, Meermeier E, Mangalaparthi KK, Kandasamy RK, Ahmann G, Wiedmeier-Nutor JE, Pandey A, Chesi M, Bergsagel PL, Fonseca R. Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention. Blood Cancer J. 2025 Feb 5; 15 (1):10 Epub 2025 Feb 05
   View PubMed
8. Fonseca R, Zhu YX, Bruins LA, Ahmann J, de Bonolo Campos C, Braggio E, Chen X, Arribas M, Darvish S, Welsh S, Meermeier E, Mangalaparthi KK, Kandasamy RK, Ahmann G, Wiedmeier-Nutor JE, Pandey A, Chesi M, Bergsagel PL, Fonseca R. Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention. Blood Cancer J. 2025 Feb 5; 15 (1):10 Epub 2025 Feb 05
   View PubMed
9. Wiedmeier-Nutor JE, Golafshar MA, Kunze KL, Esplin ED, Nussbaum RL, Jessen E, Heald B, Stewart AK, Samadder NJ, Bergsagel PL, Fonseca R. Pathogenic germ line variants in a prospective multicenter cohort of patients with multiple myeloma. Blood Neoplasia. 2025 Feb; 2 (1):100045 Epub 2024 Oct 12
   View PubMed
10. Wiedmeier-Nutor JE, Golafshar MA, Kunze KL, Esplin ED, Nussbaum RL, Jessen E, Heald B, Stewart AK, Samadder NJ, Bergsagel PL, Fonseca R. Pathogenic germ line variants in a prospective multicenter cohort of patients with multiple myeloma. Blood Neoplasia. 2025 Feb; 2 (1):100045 Epub 2024 Oct 12
    View PubMed
11. Moreno-Cortes EF, Arribas M, Martinez-Gamboa DA, Figueroa-Aguirre J, Patel R, Bihnam D, Yadav U, Wiedmeier-Nutor JE, Bergsagel L, Chhabra S, Fonseca R, Castro JE. Pre-infusion ferritin a predictive biomarker for CAR T-cell therapy in R/R multiple myeloma. Frontiers in Hematology. 2025; 4:1618331
    
12. Wiedmeier-Nutor JE, McCabe CE, O'Brien DR, Jessen E, Bonolo de Campos C, Boddicker NJ, Griffin R, Allmer C, Rabe KG, Cerhan JR, Parikh SA, Kay NE, Yan H, Van Dyke DL, Slager SL, Braggio E. Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations. Cancers (Basel). 2024 Jul 3; 16 (13) Epub 2024 July 03
    View PubMed
13. Wiedmeier-Nutor JE, McCabe CE, O'Brien DR, Jessen E, Bonolo de Campos C, Boddicker NJ, Griffin R, Allmer C, Rabe KG, Cerhan JR, Parikh SA, Kay NE, Yan H, Van Dyke DL, Slager SL, Braggio E. Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations. Cancers (Basel). 2024 Jul 3; 16 (13) Epub 2024 July 03
    View PubMed
14. Griffin R, Wiedmeier-Nutor JE, Parikh SA, McCabe CE, O'Brien DR, Boddicker NJ, Kleinstern G, Rabe KG, Bruins L, Brown S, Bonolo de Campos C, Ding W, Leis JF, Hampel PJ, Call TG, Van Dyke DL, Kay NE, Cerhan JR, Yan H, Slager SL, Braggio E. Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL. Blood Adv. 2023 Jul 11; 7 (13):3169-3179
    View PubMed
15. Griffin R, Wiedmeier-Nutor JE, Parikh SA, McCabe CE, O'Brien DR, Boddicker NJ, Kleinstern G, Rabe KG, Bruins L, Brown S, Bonolo de Campos C, Ding W, Leis JF, Hampel PJ, Call TG, Van Dyke DL, Kay NE, Cerhan JR, Yan H, Slager SL, Braggio E. Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL. Blood Adv. 2023 Jul 11; 7 (13):3169-3179
    View PubMed
16. Wiedmeier-Nutor JE, Iqbal M, Rosenthal AC, Bezerra ED, Garcia-Robledo JE, Bansal R, Johnston PB, Hathcock M, Larsen JT, Bergsagel PL, Wang Y, Reeder CB, Leis JF, Fonseca R, Palmer JM, Gysbers BJ, Mwangi R, Warsame RM, Kourelis T, Hayman SR, Dingli D, Kapoor P, Kumar SK, Durani U, Villasboas JC, Paludo J, Bennani NN, Nowakowski G, Ansell SM, Castro JE, Kharfan-Dabaja MA, Lin Y, Vergidis P, Murthy HS, Munoz J. Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2023 Jun; 23 (6):456-462 Epub 2023 Mar 07
    View PubMed
17. Wiedmeier-Nutor JE, Iqbal M, Rosenthal AC, Bezerra ED, Garcia-Robledo JE, Bansal R, Johnston PB, Hathcock M, Larsen JT, Bergsagel PL, Wang Y, Reeder CB, Leis JF, Fonseca R, Palmer JM, Gysbers BJ, Mwangi R, Warsame RM, Kourelis T, Hayman SR, Dingli D, Kapoor P, Kumar SK, Durani U, Villasboas JC, Paludo J, Bennani NN, Nowakowski G, Ansell SM, Castro JE, Kharfan-Dabaja MA, Lin Y, Vergidis P, Murthy HS, Munoz J. Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2023 Jun; 23 (6):456-462 Epub 2023 Mar 07
    View PubMed
18. Fonseca R, Arribas M, Wiedmeier-Nutor JE, Kusne YN, Gonzalez Velez M, Kosiorek HE, Butterfield RDJ, Kirsch IR, Mikhael JR, Stewart AK, Reeder C, Larsen J, Bergsagel PL, Fonseca R. Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood Cancer J. 2023 May 26; 13 (1):87
    View PubMed
19. Fonseca R, Arribas M, Wiedmeier-Nutor JE, Kusne YN, Gonzalez Velez M, Kosiorek HE, Butterfield RDJ, Kirsch IR, Mikhael JR, Stewart AK, Reeder C, Larsen J, Bergsagel PL, Fonseca R. Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood Cancer J. 2023 May 26; 13 (1):87
    View PubMed
20. Fonseca R, Arribas M, Wiedmeier-Nutor JE, Kusne YN, Gonzalez Velez M, Kosiorek HE, Butterfield RDJ, Kirsch IR, Mikhael JR, Stewart AK, Reeder C, Larsen J, Bergsagel PL, Fonseca R. Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood Cancer J. 2023 Mar 6; 13 (1):32 Epub 2023 Mar 06
    View PubMed
21. Fonseca R, Arribas M, Wiedmeier-Nutor JE, Kusne YN, Gonzalez Velez M, Kosiorek HE, Butterfield RDJ, Kirsch IR, Mikhael JR, Stewart AK, Reeder C, Larsen J, Bergsagel PL, Fonseca R. Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood Cancer J. 2023 Mar 6; 13 (1):32 Epub 2023 Mar 06
    View PubMed
22. Bering JL, Wiedmeier-Nutor JE, Sproat L, DiBaise JK. Bone marrow oxalosis with pancytopenia in a patient with short bowel syndrome: Report of a case and review of the literature. JPEN J Parenter Enteral Nutr 2023 Jan; 47 (1):165-170 Epub 2022 Oct 17
    View PubMed
23. Bering JL, Wiedmeier-Nutor JE, Sproat L, DiBaise JK. Bone marrow oxalosis with pancytopenia in a patient with short bowel syndrome: Report of a case and review of the literature. JPEN J Parenter Enteral Nutr 2023 Jan; 47 (1):165-170 Epub 2022 Oct 17
    View PubMed
24. Wiedmeier-Nutor J, Leis J. Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T. Curr Treat Options Oncol. 2022 Jun; 23 (6):904-919 Epub 2022 Apr 18
    View PubMed
25. Wiedmeier-Nutor J, Leis J. Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T. Curr Treat Options Oncol. 2022 Jun; 23 (6):904-919 Epub 2022 Apr 18
    View PubMed
26. Wiedmeier-Nutor JE, Bergsagel PL. Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup. Life (Basel). 2022 May 30; 12 (6)
    View PubMed
27. Wiedmeier-Nutor JE, Bergsagel PL. Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup. Life (Basel). 2022 May 30; 12 (6)
    View PubMed
28. Fortin Ensign SP, Gathers D, Wiedmeier JE, Mrugala MM. Central Nervous System Lymphoma: Novel Therapies. Curr Treat Options Oncol. 2022 Jan; 23 (1):117-136 Epub 2022 Feb 19
    View PubMed
29. Fortin Ensign SP, Gathers D, Wiedmeier JE, Mrugala MM. Central Nervous System Lymphoma: Novel Therapies. Curr Treat Options Oncol. 2022 Jan; 23 (1):117-136 Epub 2022 Feb 19
    View PubMed
30. Xie Z, Saliba AN, Abeykoon J, Majeed U, Almquist DR, Wiedmeier-Nutor JE, Bezerra E, Andrade-Gonzalez X, Hickman A, Sorenson K, Rakshit S, Wee C, Tella SH, Kommalapati A, Abdallah N, Pritchett J, De Andrade M, Uprety D, Badley A, Manochakian R, Ailawadhi S, Bryce AH, Hubbard JM, Gangat N, Thompson CA, Witzig TE, McWilliams RR, Leventakos K, Halfdanarson TR. Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies. JCO Oncol Pract. 2021 Sep; 17 (9):e1382-e1393 Epub 2021 June 14
    View PubMed
31. Xie Z, Saliba AN, Abeykoon J, Majeed U, Almquist DR, Wiedmeier-Nutor JE, Bezerra E, Andrade-Gonzalez X, Hickman A, Sorenson K, Rakshit S, Wee C, Tella SH, Kommalapati A, Abdallah N, Pritchett J, De Andrade M, Uprety D, Badley A, Manochakian R, Ailawadhi S, Bryce AH, Hubbard JM, Gangat N, Thompson CA, Witzig TE, McWilliams RR, Leventakos K, Halfdanarson TR. Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies. JCO Oncol Pract. 2021 Sep; 17 (9):e1382-e1393 Epub 2021 June 14
    View PubMed
32. Aslam F, Wiedmeier JE, DiCaudo DJ. A Man With Recurrent Fever, Episodic Rash, and Pain. Arthritis Care Res (Hoboken). 2021 Aug; 73 (8):1106-1113 Epub 2021 July 14
    View PubMed
33. Aslam F, Wiedmeier JE, DiCaudo DJ. A Man With Recurrent Fever, Episodic Rash, and Pain. Arthritis Care Res (Hoboken). 2021 Aug; 73 (8):1106-1113 Epub 2021 July 14
    View PubMed
34. Wiedmeier JE, Mountjoy LJ, Buras MR, Kosiorek HE, Coppola KE, Verona PM, Cook CB, Karlin NJ. Mortality and glycemic control among patients with acute and chronic myeloid leukemia and diabetes: a case-control study. Future Sci OA. 2020 Oct 26; 7 (1):FSO639
    View PubMed
35. Wiedmeier JE, Mountjoy LJ, Buras MR, Kosiorek HE, Coppola KE, Verona PM, Cook CB, Karlin NJ. Mortality and glycemic control among patients with acute and chronic myeloid leukemia and diabetes: a case-control study. Future Sci OA. 2020 Oct 26; 7 (1):FSO639
    View PubMed
36. Wiedmeier JE, Noel P, Lin W, Von Hoff DD, Han H. Single-Cell Sequencing in Precision Medicine. Cancer Treat Res. 2019; 178:237-252
    View PubMed
37. Wiedmeier JE, Noel P, Lin W, Von Hoff DD, Han H. Single-Cell Sequencing in Precision Medicine. Cancer Treat Res. 2019; 178:237-252
    View PubMed
38. Wiedmeier JE, Ohlrich A, Chu A, Rountree MR, Turker MS. Induction of the long noncoding RNA NBR2 from the bidirectional BRCA1 promoter under hypoxic conditions. Mutat Res. 2017 Feb; 796:13-19 Epub 2017 Feb 16
    View PubMed
39. Wiedmeier JE, Ohlrich A, Chu A, Rountree MR, Turker MS. Induction of the long noncoding RNA NBR2 from the bidirectional BRCA1 promoter under hypoxic conditions. Mutat Res. 2017 Feb; 796:13-19 Epub 2017 Feb 16
    View PubMed
40. Wiedmeier JE, Kato C, Zhang Z, Lee H, Dunlap J, Nutt E, Rattray R, McKay S, Eide C, Press R, Mori M, Druker B, Dao KH. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women. Exp Hematol. 2016 Sep; 44 (9):857-865.e5 Epub 2016 May 26
    View PubMed
41. Wiedmeier JE, Kato C, Zhang Z, Lee H, Dunlap J, Nutt E, Rattray R, McKay S, Eide C, Press R, Mori M, Druker B, Dao KH. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women. Exp Hematol. 2016 Sep; 44 (9):857-865.e5 Epub 2016 May 26
    View PubMed
42. McKnight RA, Yost CC, Yu X, Wiedmeier JE, Callaway CW, Brown AS, Lane RH, Fung CM. Intrauterine growth restriction perturbs nucleosome depletion at a growth hormone-responsive element in the mouse IGF-1 gene. Physiol Genomics. 2015 Dec; 47 (12):634-43 Epub 2015 Oct 20
    View PubMed
43. McKnight RA, Yost CC, Yu X, Wiedmeier JE, Callaway CW, Brown AS, Lane RH, Fung CM. Intrauterine growth restriction perturbs nucleosome depletion at a growth hormone-responsive element in the mouse IGF-1 gene. Physiol Genomics. 2015 Dec; 47 (12):634-43 Epub 2015 Oct 20
    View PubMed
44. Wiedmeier JE, Joss-Moore LA, Lane RH, Neu J. Early postnatal nutrition and programming of the preterm neonate. Nutr Rev. 2011 Feb; 69 (2):76-82
    View PubMed
45. Wiedmeier JE, Joss-Moore LA, Lane RH, Neu J. Early postnatal nutrition and programming of the preterm neonate. Nutr Rev. 2011 Feb; 69 (2):76-82
    View PubMed